Atrium Therapeutics, Inc. Common Stock (RNA) institutional holders · rev $18.8M
Atrium Therapeutics, Inc. Common Stock 13F cache, top 2 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.
| Holder | Shares | Value | Report |
|---|---|---|---|
| STATE STREET CORP | 271,762 | $3.7M | 2026-06-30 |
| FMR LLC | 33,532 | $451.0K | 2026-06-30 |
RNA institutional holders FAQ
How many RNA 13F holders are listed on this page?
This page lists 2 cached Atrium Therapeutics, Inc. Common Stock (RNA) 13F holders. Holders: https://lician.com/institutional/rna
Who is the largest RNA 13F holder by reported value?
The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/rna/93751. Holders: https://lician.com/institutional/rna
What value and shares did the largest RNA 13F holder report?
STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 271,762 shares and a value of $3.7M.
What is the latest RNA 13F report date on this page?
The latest cached 13F report date on this Atrium Therapeutics, Inc. Common Stock (RNA) holders table is Jun 30, 2026.
Which RNA 13F holders report the largest positions?
The largest cached 13F holders by reported value on this Atrium Therapeutics, Inc. Common Stock (RNA) page are STATE STREET CORP and FMR LLC. Holders: https://lician.com/institutional/rna
Where are RNA institutional holders listed?
Cached 13F holders for Atrium Therapeutics, Inc. Common Stock (RNA) are listed at https://lician.com/institutional/rna. Filer directory: https://lician.com/holders
What is RNA's latest revenue?
Latest cached Atrium Therapeutics, Inc. Common Stock (RNA) revenue for Dec 31, 2025 was $18.8M. Statements: https://lician.com/financials/rna
Not investment advice. Cached rows, not a live tape.